Jason C. Jones - Feb 17, 2022 Form 4/A Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
Chief Operating Officer
Signature
/s/ Jerome Wong (as Attorney-in-Fact)
Stock symbol
EKSO
Transactions as of
Feb 17, 2022
Transactions value $
$0
Form type
4/A
Date filed
4/4/2024, 09:21 PM
Date Of Original Report
Jun 15, 2023
Previous filing
Apr 7, 2022
Next filing
Mar 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Award $0 +3.45K +300.96% $0.00 4.59K Feb 17, 2022 By 401(k) F1
transaction EKSO Common Stock Award $0 +10.8K +235.24% $0.00 15.4K Jun 12, 2023 By 401(k) F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 15, 2023, the Reporting Person filed a Form 4 that stated the incorrect number of shares of common stock acquired in connection with the Issuer's 401(k) plan matching contribution which occurred on 2/17/2022. This amendment corrects such inaccuracy and the related total number of securities indirectly owned at that date and subsequently.